Debt-to-equity of BioCrude Technologies USA, Inc. from 31 Mar 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
BioCrude Technologies USA, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2018 to 30 Sep 2025.
  • BioCrude Technologies USA, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was -105%, a 10% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

BioCrude Technologies USA, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 -105% +12% +10% 30 Sep 2025
Q2 2025 -109% +6% +5.1% 30 Jun 2025
Q1 2025 -113% -3% -2.3% 31 Mar 2025
Q4 2024 -116% -6% -5.7% 31 Dec 2024
Q3 2024 -117% -5% -4.5% 30 Sep 2024
Q2 2024 -114% -2% -2% 30 Jun 2024
Q1 2024 -111% +2% +1.5% 31 Mar 2024
Q4 2023 -110% 31 Dec 2023
Q3 2023 -112% 30 Sep 2023
Q2 2023 -112% 30 Jun 2023
Q1 2023 -113% 31 Mar 2023
Q4 2021 -193% -74% -61% 31 Dec 2021
Q3 2021 -232% -124% -115% 30 Sep 2021
Q2 2021 -198% -90% -84% 30 Jun 2021
Q1 2021 -149% -41% -38% 31 Mar 2021
Q4 2020 -120% -11% -9.6% 31 Dec 2020
Q3 2020 -108% +4% +3.7% 30 Sep 2020
Q2 2020 -108% +15% +12% 30 Jun 2020
Q1 2020 -108% +42% +28% 31 Mar 2020
Q4 2019 -109% +103% +49% 31 Dec 2019
Q3 2019 -112% +71% +39% 30 Sep 2019
Q2 2019 -123% +28% +18% 30 Jun 2019
Q1 2019 -150% -25% -20% 31 Mar 2019
Q4 2018 -213% 31 Dec 2018
Q3 2018 -183% 30 Sep 2018
Q2 2018 -150% 30 Jun 2018
Q1 2018 -125% 31 Mar 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.